ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,186.00
      0.93%
      Dow Jones
      40,287.53
      0.00%
      Brent Oil
      81.46
      -1.00%
      Bitcoin
      67,412.25
      -1.09%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Celadon Pharmaceuticals Plc (CEL) Quote

      Celadon Pharmaceuticals Plc

      Celadon Pharmaceuticals Plc (CEL)

      Challenger Gold Limited
      59.50
      0.00
      ( 0.00% )
      Updated: 03:00:00
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      59.50
      Bid
      57.00
      Ask
      62.00
      Volume
      2,825
      59.50 Day's Range 59.50
      56.00 52 Week Range 150.00
      Market Cap
      39.26M
      Previous Close
      59.50
      Open
      59.50
      Last Trade
      965
      @
      60.9
      (O)
      Last Trade Time
      07:24:17
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      45,623
      Shares Outstanding
      65,982,712
      Dividend Yield
      -
      PE Ratio
      -5.50
      Earnings Per Share (EPS)
      -0.11
      Revenue
      149k
      Net Profit
      -7.14M

      About Celadon Pharmaceuticals Plc

      Sector
      Investment Advice
      Industry
      Investment Advice
      Website
      celadonpharma.co.uk
      Headquarters
      London, Gbr
      Founded
      1970
      Celadon Pharmaceuticals Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 59.50p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 56.00p to 150.00p.

      Celadon Pharmaceuticals currently has 65,982,712 shares outstanding. The market capitalization of Celadon Pharmaceuticals is £39.26 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.50.

      CEL Latest News

      More News

      EARNINGS AND TRADING: Gateley earnings fall; 4Global revenue rises

      The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by A ...

      July 16 2024
      Alliance News

      Celadon Pharmaceuticals PLC Successful Completion of Eighth Harvest of 2024

      Celadon Pharmaceuticals PLC 16 July 2024     Celadon Pharmaceuticals Plc   ("Celadon", the "Group" or the "Company")   Successful completion of eighth harvest of 2024   On track for fifteen...

      July 16 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Third Admission of Shares

      Celadon Pharmaceuticals PLC 15 July 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company" or the "Group")   Third Admission of Shares   London, 15 July 2024 - Celadon...

      July 15 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Result of AGM

      Celadon Pharmaceuticals PLC 28 June 2024     Celadon Pharmaceuticals Plc   ("Celadon" or the "Company")   Result of Annual General Meeting   London, UK, 28 June 2024: Celadon Pharmaceuticals...

      June 28 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Second Admission of Shares

      Celadon Pharmaceuticals PLC 07 June 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company" or the "Group")   Second Admission of Shares   London, 07 June 2024 - Celadon...

      June 07 2024
      RNS Regulatory News

      ...

      June 03 2024
      Alliance News

      Celadon Pharmaceuticals PLC Publication of Annual Report & Notice of AGM

      Celadon Pharmaceuticals PLC 03 June 2024   Celadon Pharmaceuticals Plc   ("Celadon" or the "Company")    Publication of Annual Report and Notice of Annual General Meeting   London, 3 June...

      June 03 2024
      RNS Regulatory News

      TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

      The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

      May 23 2024
      Alliance News

      Celadon Pharmaceuticals PLC Supply of Products to New US Customer

      Celadon Pharmaceuticals PLC 23 May 2024     Celadon Pharmaceuticals Plc   ("Celadon", or the "Company")   Supply of Cannabis-Based Products to New US Customer London, 23 May 2024 - Celadon...

      May 23 2024
      RNS Regulatory News

      Celadon Pharmaceuticals PLC Exercise of Share Options and Total Voting Rights

      Celadon Pharmaceuticals PLC 15 May 2024     Celadon Pharmaceuticals Plc   ("Celadon", or the "Company")   Exercise of Share Options and Total Voting Rights   London, 15 May 2024 - Celadon...

      May 15 2024
      RNS Regulatory News
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10059.561.5569880159.48818716DE
      4-14.5-19.59459459467479564560365.76250192DE
      12-43-41.9512195122102.5110564562378.58788964DE
      26-35.5-37.368421052695120564677190.37721976DE
      52-90.5-60.3333333333150150563494797.84257626DE
      156-125.5-67.8378378378185185494696798.38397407DE
      260-39.5-39.898989899993304950189131.87095204DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SERVServe Robotics Inc
      $ 11.38
      (50.73%)
      		17.62M
      RRRichtech Robotics Inc
      $ 1.95
      (32.65%)
      		8.75M
      NCPLNetcapital Inc
      $ 0.134
      (28.85%)
      		22M
      CISOCISO Global Inc
      $ 0.7133
      (19.88%)
      		1.63M
      MLGOMicroAlgo Inc
      $ 3.17
      (18.73%)
      		2.87M
      HUBCWHub Cyber Security Ltd
      $ 0.0121
      (-47.39%)
      		1.65k
      XCURExicure Inc
      $ 0.384
      (-28.24%)
      		177.81k
      VVOSVivos Therapeutics Inc
      $ 2.05
      (-16.33%)
      		1
      RYAAYRyanair Holdings PLC
      $ 98.37
      (-13.95%)
      		36.18k
      SNTGSentage Holdings Inc
      $ 2.14
      (-13.71%)
      		20.61k
      NCPLNetcapital Inc
      $ 0.134
      (28.85%)
      		22M
      SERVServe Robotics Inc
      $ 11.38
      (50.73%)
      		17.62M
      RRRichtech Robotics Inc
      $ 1.95
      (32.65%)
      		8.75M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.2251
      (4.41%)
      		3.02M
      SQQQProShares UltraPro Short QQQ
      $ 8.23
      (-2.72%)
      		2.95M

      Discussion

      View Full Feed
      jedijazz jedijazz 38 seconds ago
      $CYCA: Cytta Corp (CYCA) offers CyttaCOMMS incident management system with real-time video & audio streams for ongoing, relevant, actionable intelligence for First Responders. CyttaCARES is a game-changer in ensuring the safety of children in educational institutions and beyond. www.cytta.com #OTCQB
      CYCA
      Minddoc7 Minddoc7 1 minute ago
      COINTELEGRAPH Article: Arkham transfers $487M ARKMs to Coinbase Prime for tax compliance.
      by Amaka Nwaokocha July 21, 2024
      https://cointelegraph.com/news/arkham-transfers-304-million-arkm-coinbase-prime-custody
      COIN
      TurboDiesel06 TurboDiesel06 3 minutes ago
      https://x.com/TPSAsiaPacific/status/1815354855218909682?t=zV_3EJ9wnRNJr15Xb2bG_A&s=19
      ICNM
      WooptdooU WooptdooU 3 minutes ago
      Notforlong(s) lebby and the marcinobody guy TOOK an ENTIRE quarter of cash burn from a company with zero revenue because the in the pocket bod (mostly the SHIP JUMPER) allowed it. Who does that?

      They all sold and made millions off of fools like me and all the helplessly hopeful penny
      LWLG
      hedge_fun hedge_fun 3 minutes ago
      Isn’t the issue the divers are needed……

      to assist the device in the scan?

      5 years ago this thing was said to be autonomous and more efficient than anything on the market.

      https://investorshub.advfn.com/uimage/uploads/2020/2/23/dkqbrTinkerbell_2.0.PNG
      SFRX
      Mufaso Mufaso 3 minutes ago
      IMO Oral obesity drugs most likely to succeed based on data so far are LLY’s Orforglipron, VKTX’s VK2735 and Roche’s CT-996.

      Orforglipron which is the most advanced, has decent weight loss plus a tolerability profile “consistent with the class” . Results from orforglipron's phase 3 w
      LLY VKTX
      green maschine green maschine 3 minutes ago
      Good morning HOLO. This looks good for a bounce.
      HOLO
      FDApproved FDApproved 4 minutes ago
      Pluri’s CDMO to Manufacture Kadimastem’s Cell Therapy Candidates

      https://www.contractpharma.com/contents/view_breaking-news/2024-07-18/pluris-cdmo-to-manufacture-kadimastems-cell-therapy-candidates/
      CDMO
      Preciouslife1 Preciouslife1 4 minutes ago
      https://www.mlb.com/news/shohei-ohtani-hits-473-foot-home-run-vs-red-sox
      PEACHMAN PEACHMAN 5 minutes ago
      Right now IFUS is probably the smallest cattle feed company in the world that has created and developed one the greatest scientific breakthroughs in the last 200 years with the discovery of breaking down lignin into an edible cattle feed.


      Nothing exceeds lignin as an energy f
      IFUS
      nssrr5 nssrr5 6 minutes ago
      And some good news out this morning as well.
      TLRY
      Katfish Katfish 8 minutes ago
      Stocks with buying interest early AM:
      SERV
      CTM
      TELL
      MLGO
      CISO
      AMIX
      NOK
      CYN
      AMIX CISO MLGO
      Pennies_Envy Pennies_Envy 8 minutes ago
      It’s possible imo
      HIRU
      show_me_money show_me_money 8 minutes ago
      Replying to yourself. Lol. Great conversation. IFUS STRONG $$$$"
      IFUS
      RealDutch RealDutch 8 minutes ago
      I have been advised on funding receipt that it will hit our account today through wednesday anytime...

      That is another delay, Laxmi. Money was supposed to be wired July 12/15 and was supposed to be in our account no later than July 17. That was a certainty. Then it was July 19. Then i
      ITUP
      XMaster2023 XMaster2023 8 minutes ago
      You might get that opportunity to swear under Oath. I would still bet your real first name is Adam.
      NWBO
      BigBang BigBang 9 minutes ago
      My head is spinning and about to come off!
      COOP
      Mark Mark 10 minutes ago
      $PET 1.35 keep on watch, from Friday form 4 for 1m+ shares buy

      (NASDAQ:PET) 10% owner John P Szabo Jr acquired a total of 1,080,000 shares at an average price of $1.39. To acquire these shares, it cost around $1.47 million.
      PET
      Mufaso Mufaso 11 minutes ago
      That is a good summary by Goldman Sachs of the oral obesity NME contenders at this instant in time although I would say the table entries regarding GI side effect (Nausea/Vomiting) warrant some discussion as at face value I believe those entries are misleading for some compounds listed. (Maybe GS h
      NVO
      WooptdooU WooptdooU 11 minutes ago
      Grifter, Welfarist lebby is notforlong(s)...eom
      LWLG
      timberwolf7 timberwolf7 11 minutes ago
      IF this is accurate, how are they going to violate these state laws??
      Or they going to just steal the remaining states with vote fraud and call it 'good enough'??
      Note: I haven't verified this, but its not the first time its been said that there ARE states where
      they can't tak
      Monksdream Monksdream 12 minutes ago
      Top 10 as 8:00 approaches long day ahead
      https://ih.advfn.com/markets/nasdaq/premarket
      jedijazz jedijazz 14 minutes ago
      $AVRW Solid Growth Reported for Seratopical Revolutions Skin Care Line with Boost from Famed Beauty Box FabFitFun and Endorsements from Key Celebrities, Influencers and Top Medical Professionals: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW) https://www.einpresswire.com/article/711238053/soli
      AVRW

      Your Recent History

      LSE
      CEL
      Celadon Pharmaceuticals
      Delayed Upgrade Clock